Crispr Therapeutics shares owned by Capital Investment Advisory Services
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Capital Investment Advisory Services
from 13F filings
Historical chart of Capital Investment Advisory Services investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Capital Investment Advisory Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Capital Investment Advisory Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $1.2M | 25k | 46.98 |
| 2024-06-30 | $1.6M | 30k | 54.01 |
| 2024-03-31 | $2.1M | 30k | 68.16 |
| 2023-12-31 | $2.0M | 32k | 62.60 |
| 2023-09-30 | $1.4M | 31k | 45.39 |
| 2023-06-30 | $1.7M | 30k | 56.14 |
| 2023-03-31 | $1.3M | 29k | 45.23 |
| 2022-12-31 | $1.1M | 27k | 40.65 |
| 2022-09-30 | $1.9M | 29k | 65.35 |
| 2022-06-30 | $1.7M | 28k | 60.75 |
| 2022-03-31 | $1.7M | 27k | 62.77 |
| 2021-12-31 | $1.5M | 20k | 75.80 |
| 2021-09-30 | $2.5M | 22k | 111.94 |
| 2021-06-30 | $3.7M | 23k | 161.90 |
| 2021-03-31 | $2.5M | 21k | 121.85 |
| 2020-12-31 | $2.6M | 17k | 153.14 |
| 2020-09-30 | $1.8M | 22k | 83.63 |
| 2020-06-30 | $2.0M | 27k | 73.48 |
| 2020-03-31 | $1.0M | 24k | 42.43 |
| 2019-12-31 | $1.4M | 24k | 60.92 |
| 2019-09-30 | $966k | 24k | 40.98 |
| 2019-06-30 | $1.2M | 24k | 49.41 |
| 2019-03-31 | $816k | 23k | 35.70 |
| 2018-12-31 | $722k | 25k | 28.56 |
| 2018-09-30 | $750k | 17k | 44.37 |
| 2018-06-30 | $1.1M | 18k | 58.79 |
| 2018-03-31 | $647k | 14k | 45.69 |
| 2017-12-31 | $242k | 10k | 23.50 |
| 2017-09-30 | $193k | 11k | 17.87 |
More positions owned by Capital Investment Advisory Services
View all positions for Capital Investment Advisory Services